Potassium calcium citrate compositions and methods for production
CA 2376017 C · Owner: Mission Pharmacal Company · Inventors: Alexandrides, George; Walsdorf, Neill B.; Pak, Charles Y. C.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A composition useful as a dietary supplement for providing potassium calcium, and citrate is presented, as well as processes for producing the composition and methods for using the composition as a dietary supplement. Administration of the composition counters bone loss associated with aging or menopause by providing bioavailable calcium and, simultaneously delivering alkali load. In , addition, administration of the composition produces a substantial increase in urinary citrate, which counters kidney-stone formation.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 19, 2000 and granted January 10, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended July 19, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 19, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.